Form4insider filings, from the source

SEC Form 4 · accession 0001628280-26-048461

CASTLE BIOSCIENCES INC · CSTL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Derek J Maetzold
Officer — Pres. & Chief Exec. Officer · Director
Period of report
Jul 14, 2026
Accepted (ET)
Jul 16, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001447362

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJul 14, 2026M550$2.39A22,029D
Common StockF2Jul 14, 2026S550$22.92D21,479D
Common StockF2,F3Jul 14, 2026S1,357$22.92D39,353IBy The Maetzold Descendants 2020 Trust
Common StockF2,F4Jul 14, 2026S1,153$22.92D33,449IBy Derek Maetzold 2020 Irrevocable Trust
Common StockF2,F5Jul 14, 2026S278$22.92D12,090IBy The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk
Common StockF2,F6Jul 14, 2026S278$22.92D12,090IBy The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold
Common StockF2,F7Jul 14, 2026S278$22.92D12,090IBy The Maetzold 2018 Remainder Trust FBO John Derek Maetzold
Common StockF2,F8Jul 14, 2026S278$22.92D12,090IBy The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold
Common StockF9holding———18,718IBy DJM Grantor Retained Annuity Trust No. 6
Common StockF10holding———44,323IBy DJM Grantor Retained Annuity Trust No. 7
Common StockF11holding———40,935IBy DJM Grantor Retained Annuity Trust No. 8

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock option (right to buy)F12$2.39Jul 14, 2026M550D—May 9, 2028Common Stock55085,117D

Explanation of responses